Melatonin Inhibits Androgen Receptor Splice Variant-7 (AR-V7)-Induced Nuclear Factor-Kappa B (NF-κB) Activation and

Vincent Wing Sun Liu1, Wing Lung Yau2, Chun Wai Tam3

  • 1School of Biomedical Sciences, The University of Hong Kong, Hong Kong, China. vwsliu@hku.hk.

Insights

Melatonin inhibits the interaction between androgen receptor variant-7 (AR-V7) and nuclear factor-kappa B (NF-κB) signaling. This disruption delays castration resistance in advanced prostate cancer, offering a potential new therapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Endocrinology

Background:

  • Advanced prostate cancer often progresses to castration resistance despite initial treatment.
  • Androgen receptor splice variant-7 (AR-V7) and nuclear factor-kappa B (NF-κB) signaling are implicated in castration-resistant prostate cancer (CRPC) pathogenesis.
  • Interleukin-6 (IL-6) is a key mediator in CRPC progression.

Purpose of the Study:

  • To investigate the interaction between AR-V7 and NF-κB/IL-6 signaling in prostate cancer cells.
  • To evaluate the effect of melatonin on AR-V7-induced NF-κB activation and IL-6 expression.
  • To explore the therapeutic potential of melatonin in delaying castration resistance.

Main Methods:

  • Utilized LNCaP and 22Rv1 prostate cancer cell lines.
  • Overexpressed AR-V7 in cell lines.
  • Assessed NF-κB activation and IL-6 gene expression.
  • Treated cells with melatonin and betulinic acid (NF-κB activator).

Main Results:

  • AR-V7 overexpression activated NF-κB and up-regulated IL-6 expression.
  • Melatonin inhibited AR-V7-induced NF-κB activation and IL-6 transcription.
  • Melatonin reduced AR-V7 mRNA expression stimulated by betulinic acid.
  • Demonstrated bi-directional positive interactions between AR-V7 and NF-κB.

Conclusions:

  • Melatonin disrupts the positive feedback loop between AR-V7 and NF-κB signaling.
  • Melatonin inhibits NF-κB activation via the MT₁ receptor pathway.
  • Melatonin holds therapeutic potential for advanced prostate cancer and CRPC management.
  • Combined androgen depletion and melatonin repletion may be a viable clinical strategy.

Related Concept Videos

RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
61.0K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.2K
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
3.8K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
8.7K
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
3.4K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.2K